# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Kamala Harris actively courts corporate leaders amidst a competitive Biden-Trump race, seeking to bridge gaps and secure busine...
https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/
https://www.investors.beamr.com/_files/ugd/4c72b2_8df60aff83a142a687481ae588068351.pdf
Amazon.com Inc. (NASDAQ: AMZN) enhances healthcare accessibility with its RxPass expansion to Medicare beneficiaries, promising...
Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $58 price target.
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the b...
CVS Health currently has a dividend yield of 4.38%, which is a quarterly dividend amount of 66.5 cents a share ($2.66 a year).